Fat storage-Inducing Transmembrane Protein 2 (FIT2) is implicated to be important in the formation of triglyceride lipid droplets.
Introduction
The maintenance of energy expenditure in mammals involves the dynamic integration of two metabolically opposed states, fasting and feeding. Fasting involves the induction of catabolic, or ATP generating pathways, while feeding engages anabolic, or ATP consuming pathways that build carbon skeletons and store energy. The integration of these states is governed by endocrine signals, such as insulin and glucose, nutrient signals such as long chain fatty acids and branched chain amino acids, adipose and gut-derived polypeptide hormones, such as leptin and Glp-1, and nutrientsensing kinases, such as AMPK and mTor. One peripheral tissue that plays an important role in energy metabolism is skeletal muscle, since it comprises a large percentage of the organism's mass, and is the major site of glucose disposal, and fatty acid and amino acid catabolism. Changes in the efficiency of substrate utilization or in the type of substrate used by skeletal muscle might affect energy balance. For example, enhancing the cataplerosis of the TCA cycle in skeletal muscle by overexpression of cytosolic PEPCK resulted in mice with increased mitochondria activity and leanness (1) . Similarly, deficiency of the mitochondrial branched-chain amino acid aminotransferase isozyme (BCAT2) resulted in enhanced energy expenditure (2) .
An anabolic pathway important for the maintenance of energy balance is the storage of triglycerides (TAG) in cells. TAG is the primary energy reservoir in most eukaryotes that is stored in structures called cytosolic lipid droplets (LD) (3) . Fatty acids stored as TAG are important for ATP production in many tissues, such as skeletal muscle, during physiological stresses such as exercise (4) (5) (6) (7) . However, excessive accumulation of TAG-rich lipid droplets in tissues such as adipose, skeletal muscle, liver and pancreas is associated with insulin resistance and type 2 diabetes (8) .
The ability to store energy in the form of TAG-rich lipid droplets is evolutionarily conserved from S. cerevisiae to humans (9) . TAGrich LDs are composed of a monolayer of phospholipids surrounding the TAG core and a unique proteome that associates with the surface of LDs (9, 10) . A common theme in the turnover of TAG from LD in many mammalian tissues is the regulation of lipase action involving perilipin proteins that is coordinated with the energy demands of the cell (9, 11, 12) . The formation of TAG LDs might also be coordinated with the energy demands of the cell. TAG-rich LDs form at the endoplasmic reticulum and require the enzymatic activity of the ER-resident membrane proteins diacylglycerol acyltransferase 1 and 2 in mammals (13) . The process of LD formation and regulation of LD formation downstream of DGAT activity are poorly understood.
Our laboratory has recently identified a two-gene family of evolutionarily conserved proteins that are important in the partitioning of newly synthesized triglyceride into lipid droplets, which we named Fat storage-Inducing Transmembrane protein 1 and 2 (FITM1/FIT1 and FITM2/FIT2) (14) . FIT proteins have 6 transmembrane domains and reside exclusively in the endoplasmic reticulum (14, 15) . FIT2 is the anciently conserved FIT family member and is ubiquitously expressed at low levels in mammalian tissues with highest expression in white adipose tissue. This expression profile of FIT2 raises the possibility that FIT2 may play a role in TAG storage in "long-term" fat depots like adipose tissue, as opposed to the more rapidly turning over TAG-LDs in muscle (5, 16) . Overexpression of FIT2 in mammalian cells in vitro and in vivo resulted in TAG LD accumulation. The process of TAG LD accumulation was found to be through the partitioning of newly synthesized TAG into LD without an increase in TAG biosynthesis. Conversely, knockdown of FIT2 in pre-adipocyte NIH 3T3-L1 cells reduced the size and number of LDs, indicating that FIT2 plays an important role in lipid droplet formation, but not TAG biosynthesis. The distinct tissue distribution pattern of FIT1 and FIT2 raises the idea that FIT2, being highly expressed in adipose, is primarily involved in the generation of large lipid droplets for long-term storage of triglycerides while FIT1 is important for generating small lipid droplets involved in the rapid mobilization of triglycerides during increased ATP demand. We took advantage of the unique biochemical function of FIT2 in LD formation to examine the effects of FIT2 expression and TAG-LDs on muscle energy metabolism. Here we report that muscle-specific overexpression of FIT2 resulted in robust reprogramming of skeletal muscle metabolism whereby reduced metabolic efficiency resulted in increased energy expenditure and decreased energy charge. The data indicate that FIT2 plays an important role in regulating energy expenditure through modulating TAG storage.
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Reagents-The following rabbit polyclonal antibodies were used for these studies: p-AKT, p-AMPK, AMPK, p-glycogen synthase, glycogen synthase, p-GSK3B, GSK3B, p-ACC, ACC, LC3B (Cell Signaling), Glut1 (Abcam), Myoglobin (Santa Cruz Biotechnology), OXPAT (Novus Biologicals) and anti-calnexin (Sigma) and mouse monoclonal AKT (Cell Signaling).
Animals-Mouse FIT2 cDNA was cloned downstream of the mouse creatine kinase promoter for use in transgenesis. CKF2 mice were backcrossed for ten generations to C57BL/6J. All experiments were conducted using 2-3 month old male transgenic and WT littermates.
Animal studies-Study protocols were approved by the Institute of Animal Studies of the Albert Einstein College of Medicine. Mice were fed a standard chow (LabDiet #5058) or high fat diet (Research Diets, Inc. #D12492) composed of 60 kcal% fat for the indicated amount of time. Body weight was monitored weekly during the study period. Prior to GTT or ITT, mice were fasted overnight for 12 hours with ad libitum access to water and then administered glucose (1g/kg) or insulin (1U/kg) i.p., respectively. Blood glucose was measured in blood samples collected from tail vain using a glucometer (Accu-Check Compact, Roche).
Tissue Culture and Adenoviral Infections-C2C12 myocytes were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine calf serum and penicillin/streptomycin. For differentiation, C2C12 cell were induced at 80 to 90% confluency by switching the cell media to DMEM supplemented with 2% horse serum (differentiation media). On day 5 of differentiation, C2C12 were infected for 12 hours in differentiation media. All experiments were performed 36 hours post infection.
C2C12 Fatty Acid Oxidation, BCAA oxidation, and Glucose Transport-C2C12 cells were differentiated in six well plates and infected with empty or C-terminal tagged FIT2 (FIT2-V5) adenovirus as described above. For fatty acid oxidation, differentiation media was then replaced with 1mL low glucose DMEM (Invitrogen) supplemented with 100µM 3 H-palmitic acid-BSA (0.4µCi/ml) and 1µM L-carnitine. After 4 hours, media was collected and centrifuged at 16,000 x g for 15 minutes in a table top centrifuge to remove cellular debris. 100µl of media was then treated with 900µl of 20mM Tris-HCl 5% w/v activated charcoal (Sigma) for 30 minutes at room temperature to absorb fatty acids. Samples were then centrifuged at 16,000 x g for 15 minutes at room temperature. 200µl of the supernatant was used to determine fatty acid oxidation by measuring tritiated water using a scintillation counter and normalized to total protein. BCAA oxidation was performed in C2C12 myotubes expressing FIT2-V5 cultured in six well plates using a pulse chase method. C2C12 myotubes were pulsed for 30 minutes with DMEM 5% horse serum supplemented with 3 H-leucine (1µCi/ml). After 30 minutes, C2C12 myotubes were was extensively washed with KrebsHenseleit buffer, and then chased for 4 hours with Krebs-Henseleit buffer supplemented with 5 mM glucose, 10 mM leucine and 0.2% (w/v) fatty acid free BSA. After 4 hours, media was collected and centrifuged at 16,000 x g for 15 minutes in a table top centrifuge to remove cellular debris. 500µl of media was then treated with 500µl of 6% perchloric acid for 30 minutes at room temperature to precipitate protein. Samples were then centrifuged at 16,000 x g for 15 minutes at room temperature. 200µl of the supernatant was used to determine BCAA oxidation by measuring tritiated water using a scintillation counter and normalized to total protein. For glucose uptake, C2C12 myotubes were starved in low glucose DMEM for 2 hours then washed twice with KRPH buffer (5mM NaH 2 PO 4 , 20mM HEPES, 1mM MgSO 4 , 1mM CaCl 2 , 136mM NaCl, 4.7mM KCl) and incubated for 20 minutes in 2mL KRPH buffer supplemented with 5µM 2-deoxy-D-glucose, 1mCi/ml 3 H-2-deoxy-D-glucose and plus or minus 100nM insulin. After 20 minutes, C2C12 myotubes were washed extensively with PBS buffer and lysed with 1mL RIPA buffer supplemented with EDTA free protease inhibitors (Roche) and phosphatase inhibitors (Calbiochem). Glucose uptake was determined by measuring 800µl of lysate using a scintillation counter and normalized to total protein. Visualization of LDs in C2C12 cells were performed as previously described using BODIPY 493/503 (15) .
Physiological Measurements-Metabolic measurements (oxygen consumption, carbon dioxide production, food intake, and physical activity) were obtained continuously using a CLAMS (Columbus Instruments) open-circuit indirect calorimetry system for 5 consecutive days and normalized to lean body mass. Mice were allowed to acclimate for 2 days in individual chambers prior to data collection.
Mitochondria Isolation and Mitochondrial ATP Production Rate-Mitochondria isolation and mitochondrial ATP production rate were performed as previously described with some modifications (17) . Briefly, 50 mg of quadriceps was homogenized in 800µl Buffer A (100 mM KCl, 50mM Tris-HCl pH 7.4, 5 mM MgCl 2 , 1.8 mM ATP, and 1 mM EDTA) plus EDTA free protease inhibitors (Roche) and spun down at 1,000 x g for 20 minutes at 4°C. The supernatant was then spun down at 10,000 x g for 10 min at 4°C. The resulting pellet was then washed in 800µl Buffer A and spun down at 9,000 x g for 10 min at 4°C. The resulting pellet was resuspended in 50µl Buffer B (180mM sucrose, 35mM KH 2 PO 4 , 10mM magnesium acetate, and 5mM EDTA) plus protease inhibitors. Protein concentration was determined by BCA protein assay (Pierce). Mitochondria lysates were then diluted 1:500 in Buffer B and immediately used to determine maximal mitochondrial ATP production rate using the following substrates for oxidation: 10mM glutamate plus 1mM malate and 35mM ADP (state 3 respiration). ATP production was monitored using the ENLITEN® ATP bioluminescence detection kit (Promega). All reactions were conducted simultaneously at 25°C for 25 minutes in a 200µl reaction volumes using 10µl of diluted mitochondria protein, 100µl of the luciferase/luciferin (rL/L) reagent, and substrates for oxidation plus or minus ADP (state 2 respiration). Mitochondrial ATP production rate was normalized to total protein.
Blood Metabolites-Blood glucose was measured under fasting conditions in blood samples collected from tail vein using a glucometer (Accu-Check Compact, Roche). Plasma insulin levels were measured under fasting conditions and after treating mice with 1g/kg glucose i.p. using ELISA (Millipore). Total serum ketone bodies and lactate was determined using a colorimetric assay (Stanbio and Bioassays). Total serum triglyceride and cholesterol levels were measured using a colorimetric assay (Infinity).
DGAT Activity Assay-DGAT activity was determined using microsomes isolated from quadriceps as previously described (18) . TAG was separated by TLC and quantified as previously described (15) .
In vivo 14-C Glucose partitioning into TAG-Mice were fasted for 4 hours and injected i.p. with universally labeled (14C)-D-glucose (310mCi/mmol, Perkin Elmer) and insulin at 2,500µCi/kg and 1U/kg, respectively. Quadriceps were collected and freeze clamped 15 minutes post injection, homogenized in 1mL PBS and spun down 16,000 x g at 4°C. 50µl of the resulting supernatant was used for scintillation counting to determine total glucose uptake. Protein concentration was determined by BCA protein assay (Pierce). Lipids were then extracted from 1mg of protein and TAG separated by TLC as previously described (15) . Radioactive TAGs were quantified by using PhosphorImager analysis and represented as a rate of (14C)-D-glucose incorporated into TAG (arbitrary units obtained from PhosphorImager analysis) per mg protein normalized to total glucose uptake.
Quantification of muscle glycogen content-Muscle glycogen content was determined in WT and CKF2 quadriceps as previously described (19) .
Ex vivo glucose transport-Ex vivo basal and insulin-stimulated glucose transport was performed using extensor digitorum longus (EDL) muscle as previously described (20) .
Histology-Quadriceps were elongated, placed on cork, covered with OCT and frozen in pre-chilled 2-methylbutane. Samples were then sectioned and stained for neutral lipids using oil red-O.
Quantification of TAG by Thin Layer Chromatography-Lipids were extracted from 1mg of protein isolated from WT and CKF2 quadriceps using chloroform:metathanol (2:1). The organic phase was transferred to glass bottom tubes and dried down under a stream of nitrogen. Total TAG was then quantified using TLC as previously described (15) . TAG was quantified from C2C12 myotubes cultured in six well plates as previously described (15) .
Gene expression analysis-cDNA was synthesized from mouse quadriceps RNA using SuperScript III first-strand cDNA synthesis kit and oligo-dT primers (Invitrogen). Gene expression analysis was assessed by quantitative SYBER Green real time PCR using a 7300 real time PCR system (Applied Biosystems). Primers were obtained from Invitrogen; sequences are available upon request. Relative quantification of each target was normalized to HPRT. ATP measurements-HPLC based nucleotide analysis was performed on freezeclamped quadriceps as previously described (21) .
Metabolite Analysis-Mass spectrometrybased metabolite profiling was performed following a 4hr fast as previously described (22) .
Western blottingTissues were homogenized in RIPA buffer plus EDTA free protease inhibitors (Roche). Protein concentration was determined by BCA protein assay (Pierce), 80ug of protein were used per sample. Samples were separated by SDS-PAGE on 8%, 12%, or 15% polyacrylamide gels, transferred to nitrocellulose membranes (Bio-Rad) and incubated with indicated antibodies. Quantification of signals was performed using an Odyssey infrared scanner (Li-Cor).
Statistical Analysis-All quantitative data are represented as mean ± SEM. P values were generated by Student's t test.
Results

FIT2 expression in skeletal muscle results in triglyceride accumulation
To examine the effects of FIT2 overexpression in skeletal muscle we generated muscle-specific FIT2 transgenic mice (CKF2) by using the mouse creatine kinase promoter. We identified two founder lines, 130 and 137, which exhibited similar levels of skeletal muscle-specific expression without enhanced expression in heart or changes in FIT1 expression ( Fig. 1A and data not shown). Since both lines exhibited similar phenotypes we arbitrarily focused on line 137 throughout these studies. CKF2 mice were viable, reproduced normally, did not die prematurely, and had similar food intake as wild-type (WT) mice (see below). We have previously demonstrated that overexpression of FIT2 in mouse liver and in cells in culture resulted in the accumulation of triglyceride (TAG) in lipid droplets (14, 15) . As expected, overexpression of FIT2 resulted in a significant intramyocellular accumulation of neutral lipid as indicated by Oil-red O staining of sections of quadriceps (Fig. 1B) . To further characterize this phenotype, total lipids were extracted from quadriceps of 12-week old WT and CKF2 mice fed a standard chow (SC) diet and analyzed using thin layer chromatography. CKF2 mice exhibited a 7-fold increase in total TAG (Fig.  1C) . Diacylglycerol acyltransferase activity was unchanged in muscles from CKF2 mice relative to WT muscle (Fig. 1D) , supporting previous findings that FIT2 does not mediate triglyceride biosynthesis (14) .
Complete protection from high fat diet-induced weight gain
Increased expression of FIT2 in skeletal muscle has a profound effect on body weight. At six weeks of age CKF2 exhibited 20% less body weight as compared to their WT littermates ( Fig.  2A , time point zero). EchoMRI analysis indicated that the difference in body weight was due to decreased fat mass and lean mass (Fig. 2B ). Decreased lean mass was not due to increased activation of atrophy pathways since Murf1 and Atrogin-1/Fbox32 were not increased, but decreased in CKF2 muscle ( Figure 3A ). However, CKF2 mice had increased levels of LC3-II compared to WT, potentially indicating an increase in autophagy (Fig. 3B ). Increased autophagy may be an indication of decreased energy state in muscle (discussed below). We then challenged CKF2 mice with high fat (HF) diet beginning at six weeks of age for 12 weeks. Surprisingly, CKF2 mice were completely protected from HF diet-induced weight gain and maintained a similar body weight and fat mass as CKF2 mice on a SC diet ( Fig. 2A,B) . These findings raised the possibility that FIT2 overexpression might be affecting energy expenditure.
FIT2 expression increases energy expenditure
Several possible mechanisms can contribute to the maintenance of body weight in CKF2 mice on SC and HF diet relative to their respective WT controls, namely decreased food intake, increased voluntary physical activity, and increased thermogenesis. Because CKF2 mice are leaner than WT mice even when fed a SC diet, we focused the remainder of our studies on mice fed a SC diet. CKF2 mice exhibited similar food intake as WT mice, and had decreased physical activity compared to WT mice (Fig. 4A,B) . CKF2 mice had decreased body temperature compared to WT littermates that was correlated with significantly decreased UCP-1 protein levels in brown adipose tissue compared to WT mice (Fig. 4C,D) . In addition, UCP-3 expression in skeletal muscle was unchanged (Fig. 4E ). An alternative explanation for the leanness of CKF2 mice and protection from HF diet-induced weight gain is that CKF2 mice have enhanced energy expenditure independent of enhanced thermogenesis. To determine the mechanisms by which CKF2 mice are lean and resistant to diet-induced weight gain we measured energy expenditure using indirect calorimetry of mice fed a SC diet. We chose to examine SC-fed mice because CKF2 mice fed a SC diet were already protected from body weight gain over time ( Fig. 2A ) and thus we could avoid complicating effects of HF diet on our analysis of metabolism. CKF2 mice had increased oxygen consumption in both the light and dark cycles as compared to WT mice, indicating increased energy expenditure (Fig. 4F ). CKF2 mice also exhibited a significant increase in carbon dioxide production compared to WT mice (Fig. 4F ). Respiratory quotient (RQ) was calculated to determine if CKF2 mice have a particular preference for carbohydrate or fatty acids in their substrate utilization (Fig. 4F) . RQ in CKF2 and WT mice increased from the light phase to the dark phase indicating that CKF2 mice were similarly metabolically flexible as WT mice. CKF2 mice did show a slight, but significant reduction in RQ in the dark phase, which reflects a selective decline in glucose oxidation relative to fatty acid and/or amino acid oxidation. However, given that CKF2 mice had significantly higher plasma ketone bodies (Table 1) , oxidation of fatty acids by liver partly explains the small decrease in RQ. We observed a significant increase in serum triglyceride, free fatty acids and small but significant decrease in cholesterol. Levels of serum lactate were unchanged (Table 1) .
FIT2 enhances basal glucose transport
Intramyocellular accumulation of lipids has been correlated with insulin resistance and type II diabetes (8) . The increased intramyocelllular TAG accumulation in skeletal muscle and decreased RQ prompted us to analyze glucose and insulin tolerance. CKF2 mice fed SC diet exhibited decreased fasting glucose levels as compared to WT littermates (Fig. 5A) . Moreover, CKF2 mice fed HF diet maintained low fasting glucose to a similar level as CKF2 mice fed a SC diet, indicating a major change in glucose metabolism in CKF2 mice compared to WT mice (Fig. 5A) .
Glucose tolerance tests (GTT) experiments in SC-fed animals indicated that CKF2 mice had a more rapid glucose excursion rate than WT mice ( Figure 5B ). This enhanced glucose tolerance was not a result of an increased insulin response, as CKF2 mice exhibited similar serum insulin levels as WT mice at the 15-minute time point of the GTT (Fig. 5C) . In contrast to enhanced glucose tolerance, CKF2 mice exhibited an attenuated response to insulin during insulin tolerance tests (ITT), where insulin did not enhance glucose disposal (Fig. 5D ). This decrease in response to insulin in CKF2 mice was correlated with decreased insulin-induced phosphorylation of AKT in skeletal muscle (Fig.  5E ). Taken together, the results of the GTT and ITT suggested that CKF2 mice had increased basal glucose transport independent of insulinstimulated glucose transport mediated by Glut4. This result prompted us to quantify the levels of Glut4 and Glut1 in skeletal muscle of CKF2 mice. Western blot analysis of CKF2 quadriceps indicated that while Glut4 levels were similar between CKF2 and WT mice, in CKF2 mice there was expression of Glut1, a glucose transporter not typically expressed in adult skeletal muscle (23) (Fig. 5F ). Since Glut1 has a similar K m for transport of glucose as Glut4 (24, 25) , it is likely that the low glycemia and increased glucose tolerance in CKF2 mice is the result of Glut1 expression. These results are consistent with studies conducted in a transgenic mouse having skeletal muscle-specific overexpression of Glut1 that exhibited low plasma glucose, increased basal glucose transport and is unresponsive to insulin (26, 27) .
Skeletal muscles from CKF2 mice had significantly increased levels of pyruvate dehydrogenase kinase 1 (PDK1), suggestive of a block in pyruvate oxidation by pyruvate dehydrogenase (Fig. 5F ). To determine the degree to which increased glucose disposal in CKF2 mice is due to uptake by skeletal muscle, we quantified both basal and insulin-stimulated glucose transport in skeletal muscle ex vivo. Basal glucose transport in CKF2 EDL mice was significantly elevated relative to WT controls and, remarkably, was not significantly increased by insulin stimulation (Fig. 5G ). The data indicate that skeletal muscle of CKF2 mice is maximally permeable to glucose in the basal state, supporting a role for Glut1 expression in mediating glucose transport in skeletal muscle of CKF2 mice.
Utilization of glucose for glycerol-3-phosphate synthesis
Given the high rate of glucose transport in skeletal muscle of CKF2 mice, we determined the metabolic fate of glucose taken up by skeletal muscle from CKF2 mice. High rates of glucose transport can enhance glycogen synthesis (28) . However, glycogen levels in muscles from CKF2 mice where significantly decreased compared to WT muscle, which correlated with increased levels of phospho-glycogen synthase and decreased levels of phospho-Gsk3-beta, indicating decreased glycogen synthesis in muscles from CKF2 mice (Fig. 6A,B ) . The utilization of glucose for pyruvate oxidation in the TCA cycle was also unlikely given the high levels of PDK1 expression (Fig. 5F ). Glucose-derived carbons are also used to generate the glycerol backbone for triglyceride biosynthesis. Because glycerol kinase activity is minimal in skeletal muscle, the glycerol-3-phosphate substrate required for de novo glycerolipid synthesis originates directly from glycolysis or from glyceroneogenesis, a process that draws on carbons from pyruvate, lactate, alanine, and TCA cycle intermediates such as malate (29, 30) . Since CKF2 mice exhibited a 7-fold increase in intramyocellular TAG we hypothesized that CKF2 mice had a high rate of glycerol 3-phosphate synthesis derived from glucose for the purpose of TAG synthesis. To determine the contribution of glucose to glycerol 3-phosphate synthesis in vivo we injected WT and CKF2 mice with universally labeled [14C]-glucose together with insulin to equalize glucose transport between CKF2 and WT mice and analyzed the amount of label partitioned into triglyceride from quadriceps muscle. CKF2 mice exhibited a significant 5-fold increase in [14C]-glucose incorporation into TAG (Fig. 6C) . Taken together, these results indicated that overexpression of FIT2 in skeletal muscle drives glucose uptake for the purpose of TAG glycerol synthesis and not glycogen synthesis.
FIT2 alters fuel utilization in skeletal muscle
In order to determine how glucose utilization might relate to enhanced energy expenditure in CKF2 mice, we employed a mass spectrometry-based targeted metabolomics approach to measure a comprehensive panel of muscle metabolites in mice that were fasted for 4 hrs. CKF2 mice exhibited high muscle lactate and low pyruvate levels compared to WT mice. The rise in the lactate to pyruvate ratio in CKF2 muscle could indicate a highly reduced cytosolic redox state due to enhanced glucose uptake and glycolytic flux, whereas the CKF2-associated decline in pyruvate is consistent with increased glucose utilization for TAG biosynthesis (Fig.  7A) . Acylcarnitine metabolites are generated as byproducts of incomplete substrate catabolism and can therefore report on shifts in fuel selection and/or flux limitations at specific mitochondrial enzymes (22) . Acetylcarnitine (C2) derives from mitochondrial acetyl-CoA, the universal end product of glucose, fatty acid and amino acid catabolism that in turn fuels the TCA cycle (6, 22) . C2 was significantly increased in muscles of CKF2 mice, suggesting enhanced degradation of one or more of these substrates, and/or impaired TCA cycle flux (Fig. 7B) . By contrast, CKF2 mice exhibited a significant decrease in evennumbered medium and long-chain acyl-carnitine species (C14, C16, C18) that are generated as byproducts of beta-oxidation (Fig. 7C) , a signature that might reflect diminished rates of fat oxidation (22) . Consistent with this prediction, expression of several known PPARalpha-regulated genes encoding proteins important in the transport (carnitine palmitoyltransferase 1β and carnitine Oacetyltransferase) and oxidation of acyl-carnitines (very long chain acyl-CoA dehydrogenase, and medium chain acyl-CoA dehydrogenase) were significantly lower in skeletal muscle of CKF2 mice than in muscle from WT mice (Fig. 7D) . Moreover, levels of Perilipin 5/OXPAT, also a PPARalpha target and proposed to be important in the regulation of lipolysis in skeletal muscle (31, 32) , was significantly reduced in muscles of CKF2 mice (Fig. 7E) .
Odd-chain acylcarnitine species such as C3 and C5:1 are derived from oxidation of the branch chain amino acids valine, isoleucine, whereas C5 acylcarnitine is derived from oxidation of leucine (22) . Oxidation of valine also contributes to the C4-acylcarnititne pool (22) . We observed a significant increase in odd chain acylcarnitine species (C3,C5:1) and C4-acylcarntinine, strongly suggesting a large increase in BCAA oxidation in quadriceps of CKF2 mice (Fig. 7F) . Further supportive of an increase in BCAA oxidation, muscle concentrations of valine, leucine and isoleucine were decreased and glutamate and aspartate were increased in the CKF2 mice (Fig.  7G ). Glutamate and aspartate are products of aminotransferases in amino acid catabolism and accumulate upon increases in BCAA catabolism. During physiological challenges that limit glucose availability, such as starvation or prolonged exercise, muscle catabolism of BCAA provides anaplerotic substrate to support the TCA cycle. Indeed, we found that concentrations of succinate, fumurate and malate were significantly increased in muscles of CKF2 mice, consistent with the use of BCAA-derived carbons to "fill" the TCA cycle at a site distal to a-ketoglutarate dehydrogenase (Fig. 7H) . Based on these results we surmised that CKF2 muscles rely primarily on amino acids as a principal source of oxidative substrate; whereas glycolytic intermediates and fatty acids appear to be preferentially diverted toward triglyceride synthesis.
FIT2 expression decreases energy state in skeletal muscle
Because triacylglycerol synthesis is an ATP-consuming process that siphons carbons and reducing equivalents away from catabolic fates, and because amino acids are the least efficient carbon fuel for ATP production, we predicted that oxidation of BCAA would not be sufficient to sustain a normal energy charge in muscle. Indeed, the concentration of ATP as measured by HPLC in skeletal muscle of CKF2 mice was significantly reduced relative to WT mice (Fig. 8A) . One consequence of low ATP in CKF2 mice was increased phosphorylated AMPK and phosphorylation of the AMPK substrate ACC (Fig. 8B) . Low ATP levels could arise from decreased energy efficiency coupled with the ATP costs of skeletal muscle triacylglycerol synthesis, as described above.
Alternatively, we also considered the possibility that FIT2 overexpression results in defective mitochondria and impaired respiratory function. The latter mechanism seemed less likely because a decrease in NADH flow into the electron transport chain would be predicted to inhibit TCA cycle activity at the level of a-ketoglutarate dehydrogenase and malate dehydrogenase (33) . The skeletal muscle organic acid profile shown in Figure 3 argues against this option. To directly evaluate electron transport chain function we measured mitochondrial ATP production rate during state 2 and state 3 respiration in isolated mitochondria from CKF2 and WT skeletal muscle. The mitochondrial ATP production rate in skeletal muscle of CKF2 mice was found to be similar to WT (Fig. 8C) , indicating that decreased energy state in muscles from CKF2 mice was not due to inherent defects in respiratory function and the ability of mitochondria to synthesize ATP. Overexpression of FIT2 did not result in reprogramming of C2C12 myotube metabolism.
To determine if any of the metabolic phenotypes described above in CKF2 mice have cell-autonomous components, we overexpressed FIT2 in a skeletal muscle cell line, C2C12 that can be differentiated into myotubes. Overexpression of FIT2 in C2C12 myotubes resulted in LD accumulation (Fig 9A) without a significant increase in cellular TAG levels (Fig 9B) . Typically, FIT2 expression in HEK293 cells in culture resulted in a modest 2-fold increase in cellular TAG, without an increase in TAG biosynthesis (14, 15) . However, we observed a small but significant increase in fatty acid oxidation in C2C12 myotubes expressing FIT2 (Fig. 9C) , likely explaining the lack of a 2-fold increase in cellular TAG. No significant increase in p-AMPK levels was observed (Fig 9D) . Basal and insulin-stimulated glucose transport, p-AKT levels, Glut1 and Glut4 levels, and BCAA oxidation were unchanged in response to FIT2 expression (Fig. 9D, E, F, G) . Together, these findings indicate that the metabolic effects of FIT2 overexpression in skeletal muscle could not be recapitulated on a cell-autonomous level in C2C12 cells.
Discussion
In the present study we showed that overexpression of FIT2 in skeletal muscle resulted in increased concentration of intramyocellular triglyceride (IMTG), increased utilization of branch chain amino acids (BCAA), profoundly decreased cellular ATP levels, and complete protection from high fat diet-induced weight gain. Taken together, these results support the conclusion that FIT2 plays an important role in regulating skeletal muscle metabolism and energy expenditure and indicate a critical role of the lipid droplet in these processes in skeletal muscle.
Overexpression of FIT2 in skeletal muscle had a profound and unexpected effect on muscle energy metabolism. Of major importance is the observation that CKF2 mice were significantly leaner when fed a standard chow diet, and completely protected from weight gain when fed a high fat diet that correlated with increased energy expenditure on either a standard chow or high fat diet. These phenotypes were not explained by changes in food intake, physical activity, or thermogenesis. It is important to emphasize that CKF2 mice were not in a negative energy state because they did not lose body weight over time, but rather maintained a lower body weight and skeletal muscle energy balance. The first law of thermodynamics would dictate that CKF2 mice must have uncoupling of ATP synthesis from ATP consumption. One possibility is that ATP consumed by the processes of glycerol-3-phosphate production and triglyceride synthesis outpaced the capacity for ATP production. Because maximal rates of ATP synthesis were found to be normal in isolated mitochondria from CKF2 muscle, we presume that the insufficiency lies in the supply of reducing equivalents in vivo. For example, re-routing of glucose-derived carbons into the triacylglycerol pool might result in diminished flux through pyruvate dehydrogenase and the glycerol-phosphate shuttle, both of which serve as an important source of reducing equivalents (NADH and FADH2) for the mitochondrial electron transport chain. Indeed, increased levels of PDK1 strongly supports the idea that pyruvate oxidation in limited in muscles of CKF2 mice (Fig. 5F ). Fitting with this possibility, a block in the glycerol-phosphate shuttle might invoke compensatory flux through the aspartate/malate shuttle, as suggested by the increase in muscle concentrations of these metabolites (Fig. 7H) .
CKF2 mice have many of the hallmarks of metabolic adaptations to starvation, such as low muscle ATP, high AMPK activity, increased BCAA oxidation, decreased physical activity, and decreased body temperature (34) (35) (36) . A major point of divergence from a typical starvation phenotype is that CKF2 mice have decreased oxidation of fatty acids in skeletal muscle in the face of massive accumulation of IMTG. This is of interest and indicates a unique aspect of FIT2 expression that is not seen in other mouse models having high IMTG. For example, overexpression of DGAT1 in skeletal muscle resulted in a significant increase in IMTG associated with a significant increase in fatty acid oxidation (37) . An opposite finding was obtained with a global deficiency of DGAT1 in mice that exhibited decreased IMTG coupled with decreased PPARalpha target gene expression (38) (39) (40) . These findings indicate that skeletal muscle responds to changing levels of lipid droplet TAG with significant metabolic adaptations that affect energy expenditure and PPARalpha activity. In our studies, quantification of acyl-carnitines suggested that fatty acid oxidation was decreased in CKF2 muscle relative to wild-type muscle. This phenotype was coupled with decreased PPARalpha targets involved in fatty acid oxidation and the regulation of lipolysis in skeletal muscle, including Perilipin 5/OXPAT. Perilipin 5/OXPAT is a lipid droplet-associated protein part of the Perilipin family that is highly expressed in fatty acid oxidative tissues such as skeletal muscle and is a gene target of PPARalpha (31, 41) . Data are just emerging indicating that Perilipin 5/OXPAT might play an important role in regulating lipolysis (31, 32) . Decreased TAG hydrolysis in skeletal muscle of CKF2 mice would be expected to decrease ATP production resulting from fatty acid oxidation. Our findings raise the possibility that FIT2-generated lipid droplets in CKF2 mice have a unique protein composition or subcellular localization that limits the hydrolysis of the TAG core, and more generally that the lipid droplet is a major storage depot for fatty acid activators of PPARalpha that are released upon TAG hydrolysis. This latter conclusion is supported by recent studies of adipose triglyceride lipase/desnutrin (ATGL) deficient mice (42, 43) . ATGL/desnutrin plays an important role in hydrolysis of lipid droplet TAG in skeletal muscle (44) .
Kratky and co-workers recently demonstrated that ATGL/desnutrin deficiency in macrophages resulted in increased accumulation of TAG in lipid droplets associated with decreased ATP levels (42) . Importantly, ATP deficiency was not ameliorated by supplementing ATGL/desnutrin null macrophage with glucose or fatty acids, indicating that fatty acyl-CoAs are likely first packaged into TAG and stored in lipid droplets before they can be hydrolyzed by ATGL/desnutrin for use in mitochondrial betaoxidation for ATP production. The study of Kratky co-workers further supports the important role that lipid droplets may play in regulating energy production by regulating the amount of fatty acids available for oxidation and mitochondria ATP synthesis. More recently, Zechner and co-workers demonstrated that a muscle-specific deficiency of ATGL/desnutrin resulted in a significant reduction in PPARalpha target gene expression in heart, that could be complemented by re-expression of ATGL, and independently by treatment with a PPARalpha agonist, strongly supporting a role of the lipid droplet as a storage depot for PPARalpha ligands (45) . Similar conclusions were drawn from the recent work of Sul and co-workers using an adipose-specific deficiency of ATGL/desnutrin in mice (43) .
One striking adaptation in CKF2 mice was increased muscle glucose transport. High levels of insulin-independent glucose transport in CKF2 muscles could be explained by expression of Glut1, a transporter normally not expressed in adult skeletal muscle of mice (23) . Overexpression of Glut1 in mouse skeletal muscle resulted in a similar level of insulin-independent glucose transport in which skeletal muscle was maximally permeable to glucose (26, 27) . Glut1 expression is a likely adaptation to chronic energy deprivation beginning in late embryogenesis when the MCK promoter is active to drive FIT2 transgene expression (46).
Skeletal muscle should have a finite capacity to store TAG in lipid droplets, which raises the question that if fatty acid oxidation is decreased in muscles of CKF2 mice, by what other mechanisms is the lipid droplet metabolized? One possibility is that autophagy of lipid droplets, also known as lipoautophagy (47) plays an important role in lipid droplet turnover in CKF2 mice that might allow the disposal of TAG. However, it is not known if lipoautophagy will result in a similar level of fatty acid oxidation as the ATGL mediated pathway, or instead fatty acids released from lysosomes will be used in re-esterification reactions to generate phospholipids. Nonetheless, CKF2 mice did show increased levels LC3-II suggestive of increased macroautophagy that would allow protein turnover for increased BCAA oxidation (47) .
FIT2 is the anciently conserved member of this family and is ubiquitously expressed in all tissues, with highest expression in adipose depots (14) where it is regulated directly by PPARgamma (14, 48) . FIT1 is almost exclusively expressed in skeletal muscle of mouse and human, and at much higher levels than FIT2 in skeletal muscle (14) . The distinct tissue distribution pattern of FIT1 and FIT2 raises the idea that FIT2, being highly expressed in adipose tissue, is primarily involved in the generation of large lipid droplets for longterm storage of triglycerides while FIT1 is important for generating small lipid droplets involved in the rapid mobilization of triglycerides during increased ATP demand. It will be important in future studies to determine if FIT1 and FIT2 play distinct roles in regulating muscle energy metabolism. In summary, our study indicates that FIT2 expression in skeletal muscle reprograms energy metabolism and supports an important role for the lipid droplet in regulating energy metabolism. Table 1 . CKF2 mice serum metabolites. Blood was collected from CKF2 mice after a six hour fast. Serum metabolites were measured using colorimetric assay. CKF2 exhibited increased serum TAG and FFA, this correlated with increased levels of ketone bodies likely indicating increased fatty acid oxidation by liver. Cholesterol levels were significantly elevated. Serum lactate levels were not significantly different. Data are represented as mean ± SEM; n = 4 mice. **p<.001, ***p<.0001. 
